May 1, 2026 5:18 AM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

UBS

Latest Macro 

Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid

March 20, 2023 3:03 PMMarch 20, 2023 2:09 PM Jim McFadden 0 Comments Banking, Credit Suisse, UBS

The details of UBS’ (NYSE: UBS) hastily arranged March 19 acquisition of Credit Suisse (NYSE: CS) could introduce even more

Share
Tweet
Share
Reddit
Read more
Latest Macro 

Now $3.2 Billion: Credit Suisse Price Tag Keeps Rising For UBS

March 20, 2023 10:08 AMMarch 20, 2023 10:08 AM ER Velasco 0 Comments Banking, Credit Suisse, UBS

UBS agreed to buy beleaguered rival Credit Suisse for 3 billion Swiss francs ($3.2 billion) on Sunday, with Swiss authorities

Share
Tweet
Share
Reddit
Read more
Latest Macro 

UBS Bypasses Shareholder Vote, Will Acquire Credit Suisse for Over $2 Billion

March 19, 2023 2:11 PMMarch 19, 2023 2:11 PM Hermina Paull 0 Comments Credit Suisse, UBS

UBS has finally agreed to acquire troubled Credit Suisse (NYSE: CS) for over $2 billion, following emergency meetings with regulators

Share
Tweet
Share
Reddit
Read more
Latest Macro 

Swiss Regulators Prepare to Fast-Track UBS Takeover of Credit Suisse

March 18, 2023 6:23 PM Hermina Paull 0 Comments Credit Suisse, UBS

Swiss regulators are going to expedite the takeover of troubled Credit Suisse (NYSE: CS) by UBS, foregoing shareholder consultations in

Share
Tweet
Share
Reddit
Read more
Latest Macro 

Swiss Bank UBS Cuts Value of Russian Bonds to Zero, Sparking Margin Calls

February 24, 2022 8:08 PMFebruary 24, 2022 8:08 PM Hermina Paull 0 Comments Russia-Ukraine, UBS

Swiss bank UBS Group AG triggered a cascade of margin calls on Thursday, after slashing the value of Russian debt

Share
Tweet
Share
Reddit
Read more

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Missouri Cannabis Sales Rake in $240 Million in New Tax Revenue Over Past Year
  • The Golden Triangle: British Columbia’s Exploration Hotbed
  • France Braces for Reduced Nuclear Output As Rivers Get Too Warm
  • Ontario’s Highway 407: A $60 Billion+ Tunnel Or A Pricey Buyback?
  • Horizons ETFs Warns Investors Of Termination Rights On HOD, HOU

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.